Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy

Improving 30-Day HF Readmission Rates With Biomarker-Guided Therapy

Heart Failure Epidemiology (US Data)

CHF Hospitalizations by Age, 2000 and 2010

Consequences of Heart Failure

Impact of Affordable Care Act on HF Readmission

Impact of Affordable Care Act on HF Readmission (cont)

EVEREST Study

EVEREST: NPs and Congestion Scores

Relationships Between Discharge BNP and Outcomes

Therapies With Effects on BNP Levels

DOSE-AHF Study

Telemonitoring and Home-based Care

The Importance of Serial NP Measurements for Prognostication

in Chronic HF

PROTECT Study Primary End Point: Total Cardiovascular Events

PROTECT Secondary End Points: HF Hospitalization and Rehospitalization

Guided Therapy Combined Analyses

Suggest Benefit, All-Cause Mortality

The GUIDE-IT Trial

Home Testing

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)